Actonel News: Bone drug may benefit immobile Parkinson's patients Immobilization and lack of sunlight exposure cause accelerated bone loss in people with Parkinson's disease, increasing their risk of hip fracture. But taking the bone-building drug Actonel with vitamin D seems to curb the risk of fractures in elderly men with Parkinson's disease, even though they continue to have frequent falls.